Patients were included if they were aged 18 years or older , had received alteplase within 45 h of symptom onset , and had an eligible National Institutes of Health Stroke Scale ( NIHSS ) score ( > 6 and 25 ) and premorbid ( assessed by anamnesis ) modified Rankin Scale ( mRS ) score ( 2 ) .